or Try an Advanced Search...

    Targeted Therapy Stocks List

    Symbol Grade Name % Change
    APTO F Aptose Biosciences, Inc. 4.24
    APLM F Apollomics Inc. 0.00
    ATRA F Atara Biotherapeutics, Inc. 0.65
    POAI F Predictive Oncology Inc. 0.00
    TCON F TRACON Pharmaceuticals, Inc. 0.00
    OLMA F Olema Pharmaceuticals, Inc. 0.00
    AVTX F Avalo Therapeutics, Inc. 0.00
    CRDF D Cardiff Oncology, Inc. 0.00
    CLRB D Cellectar Biosciences, Inc. 0.00
    CELC D Celcuity Inc. 1.19
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Medical Instruments & Supplies
    Related Stock Lists: Medicine Cancer Clinical Medicine Drugs Biopharmaceutical Oncology Solid Tumors Antineoplastic Drugs Biomarkers Biotechnology Blastoma Clinical Development Glioblastoma Precision Medicine Acute Myeloid Leukemia Advanced Solid Tumors Biology Cancer Therapies Cancer Treatment Cell Biology

    Related ETFs - A few ETFs which own one or more of the above listed Targeted Therapy stocks.

    Symbol Grade Name Weight
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 0.63
    XBI D SPDR S&P Biotech ETF 0.38
    SBIO D ALPS Medical Breakthroughs ETF 0.35
    LABU D Direxion Daily S&P Biotech Bull 3X Shares 0.22
    BTEC D Principal Healthcare Innovators Index ETF 0.14
    View all Targeted Therapy ETFs...
    Compare ETFs
    Compare BBC to BTEC Compare BBC to SBIO Compare SBIO to LABU

        Targeted Therapy Stocks Recent News

        Date Stock Title
        May 13 CRDF Cardiff Oncology to Present at Upcoming Investor Conferences in May
        May 13 CLRB Cellectar Biosciences Q1 2024 Earnings Preview
        May 13 AVTX Avalo Therapeutics reports Q1 results
        May 13 AVTX Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates
        May 11 ATRA Atara Biotherapeutics First Quarter 2024 Earnings: Beats Expectations
        May 10 POAI Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024
        May 9 ATRA Atara Biotherapeutics GAAP EPS of -$0.23 beats by $0.02, revenue of $27.36M beats by $2.67M
        May 9 ATRA Atara Biotherapeutics (ATRA) Reports Q1 Loss, Tops Revenue Estimates
        May 9 ATRA Atara Biotherapeutics Announces First Quarter 2024 Financial Results and Operational Progress
        May 9 OLMA Olema Pharmaceuticals GAAP EPS of -$0.56 beats by $0.02
        May 8 APLM Apollomics Announces Private Placement Financing and Addition to Board of Directors
        May 8 OLMA Olema Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update
        May 8 CELC Celcuity Inc. Schedules Release of First Quarter 2024 Financial Results and Webcast/Conference Call
        May 8 OLMA Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress
        May 8 CLRB Cellectar Biosciences to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Day
        May 7 TCON TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
        Related Industries: Biotechnology Diagnostics & Research Medical Instruments & Supplies
        Related Stock Lists: Medicine Biopharmaceutical Breast Cancer Cancer Clinical Medicine Treatment Of Breast Cancer Age Related Macular Degeneration Antiestrogens Artificial Intelligence Bioinformatics Biomarkers Biotechnology Blastoma Cancer Cell Cancer Therapies Carcinoma Cell Biology Clinical Development Clinical Trial Colorectal Cancer
        Targeted Therapy

        Targeted therapy is a type of cancer treatment that uses drugs or other substances to identify and attack specific cancer cells without harming normal cells. It works by targeting the molecules and pathways that are involved in the growth and spread of cancer cells. Targeted therapy is used to treat many types of cancer, including breast, lung, and colorectal cancer.

        Browse All Tags